{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:59:59Z","timestamp":1793019599779,"version":"4.5.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT149087"],"award-info":[{"award-number":["PJT149087"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210280","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T13:31:39Z","timestamp":1546608699000},"page":"e0210280","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":93,"title":["The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4736-1770","authenticated-orcid":true,"given":"Stephen","family":"Mac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara R.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","article-title":"Epidemiology of Lyme Disease","volume":"29","author":"PS Mead","year":"2015","journal-title":"Infect Dis Clin North Am. Elsevier Inc"},{"key":"ref2","first-page":"74","article-title":"An estimate of Lyme borreliosis incidence in Western Europe","volume":"39","author":"RA Sykes","year":"2016","journal-title":"J Public Health (Bangkok)"},{"key":"ref3","unstructured":"Centers for Disease Control and Prevention. Data and Statistics | Lyme Disease | CDC [Internet]. [cited 29 May 2017]. https:\/\/www.cdc.gov\/lyme\/stats\/<\/ext-link>"},{"key":"ref4","unstructured":"European Centre for Disease Prevention and Control. Lyme Borreliosis in Europe [Internet]. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/healthtopics\/vectors\/world-health-day-2014\/Documents\/factsheet-lyme-borreliosis.pdf<\/ext-link>"},{"key":"ref5","unstructured":"World Health Organization. WHO | World Health Day\u20147 April 2014 [Internet]. [cited 5 Feb 2018]. http:\/\/www.who.int\/campaigns\/world-health-day\/2014\/event\/en\/<\/ext-link>"},{"key":"ref6","article-title":"Lyme Disease in Canada: An Update on the Epidemiology","volume":"43","author":"S Habegger","year":"2014","journal-title":"Natl Collab Cent Infect Dis Purple Pap"},{"key":"ref7","unstructured":"Government of Canada. Federal Framework on Lyme Disease Act (S.C. 2014, c. 37) [Internet]. 2016 [cited 12 Nov 2016]. http:\/\/laws-lois.justice.gc.ca\/eng\/acts\/F-7.35\/FullText.html<\/ext-link>"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/314053","article-title":"Practice Guidelines for the Treatment of Lyme Disease","volume":"31","author":"GP Wormser","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1093\/cid\/ciq116","article-title":"Vaccines against Lyme disease: What happened and what lessons can we learn?","volume":"52","author":"GA Poland","year":"2011","journal-title":"Clin Infect Dis. United States"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: Towards a methodological framework","volume":"8","author":"H Arksey","year":"2005","journal-title":"Int J Soc Res Methodol Theory Pract"},{"key":"ref11","article-title":"The Joanna Briggs Institute Reviewers\u2019 Manual 2015: Methodology for JBI Scoping Reviews","year":"2015"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med"},{"key":"ref13","unstructured":"CADTH. Grey Matters: a practical tool for searching health-related grey literature | CADTH.ca [Internet]. [cited 14 Oct 2017]. https:\/\/www.cadth.ca\/resources\/finding-evidence\/grey-matters<\/ext-link>"},{"key":"ref14","article-title":"HTA 101: Introduction to Health Technology Assessment","author":"CS Goodman","year":"2014"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS)\u2014Explanation and elaboration: A report of the ISPOR Health Economic Evaluations Publication Guidelines Task Force","volume":"16","author":"D Husereau","year":"2013","journal-title":"Value Heal"},{"key":"ref16","unstructured":"Central Intelligence Agency. The World Factbook [Internet]. 2017 [cited 11 May 2018]. https:\/\/www.cia.gov\/library\/publications\/the-world-factbook\/rankorder\/2119rank.html<\/ext-link>"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM199208203270806","article-title":"Prevention of Lyme disease after tick bites. A cost-effectiveness analysis","volume":"327","author":"D Magid","year":"1992","journal-title":"N Engl J Med. United States"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-119-6-199309150-00010","article-title":"Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease: A cost- effectiveness analysis","volume":"119","author":"RW Lightfoot","year":"1993","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199707313370525","article-title":"Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis","volume":"337","author":"MH Eckman","year":"1997","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-128-1-199801010-00007","article-title":"Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis","volume":"128","author":"G Nichol","year":"1998","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3201\/eid0503.990302","article-title":"The cost effectiveness of vaccinating against Lyme disease","volume":"5","author":"M Meltzer","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"ref22","article-title":"Vaccines for the 21st Century: A Tool for Decision Making","author":"K Stratton","year":"1999"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archinte.161.4.554","article-title":"The cost-effectiveness of vaccination against Lyme disease","volume":"161","author":"NA Shadick","year":"2001","journal-title":"Arch Intern Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/art.10270","article-title":"Cost-effectiveness analysis of the Lyme disease vaccine","volume":"46","author":"EC Hsia","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/vbz.2013.1365","article-title":"Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study","volume":"13","author":"PM Lantos","year":"2013","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1128\/JCM.01853-13","article-title":"Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of lyme disease with noncutaneous manifestations","volume":"51","author":"GP Wormser","year":"2013","journal-title":"J Clin Microbiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/517311","article-title":"Utilization and cost of serologic tests for Lyme disease in Maryland","volume":"176","author":"GT Strickland","year":"1997","journal-title":"J Infect Dis. United States"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0149-2918(98)80081-7","article-title":"A cost-of-illness study of Lyme disease in the United States","volume":"20","author":"E Maes","year":"1998","journal-title":"Clin Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0033-3506(03)00067-2","article-title":"Lyme disease\u2014what is the cost for Scotland?","volume":"117","author":"AW Joss","year":"2003","journal-title":"Public Health. Netherlands"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3201\/eid1204.050602","article-title":"Economic impact of Lyme disease","volume":"12","author":"X Zhang","year":"2006","journal-title":"Emerg Infect Dis. Centers for Disease Control and Prevention"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1469-0691.2009.03059.x","article-title":"Neuroborreliosis\u2014an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden","volume":"16","author":"AJ Henningsson","year":"2010","journal-title":"Clin Microbiol Infect. England"},{"key":"ref32","first-page":"56","article-title":"Evaluating frequency, diagnostic quality, and cost of lyme borreliosis testing in Germany: A retrospective model analysis","volume":"6","author":"B Lohr","year":"2015","journal-title":"Clin Dev Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1540-8159.2011.03095.x","article-title":"A safe and cost-effective approach to treating lyme cardiac disease in an era of health care reform","volume":"34","author":"J Kim","year":"2011","journal-title":"PACE\u2014Pacing Clin Electrophysiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"AF Hinckley","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0116767","article-title":"Health Care Costs, Utilization and Patterns of Care following Lyme Disease","volume":"10","author":"ER Adrion","year":"2015","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ttbdis.2014.09.004","article-title":"Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis","volume":"6","author":"B Lohr","year":"2015","journal-title":"Ticks Tick Borne Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/eurpub\/ckw269","article-title":"The cost of Lyme borreliosis","volume":"27","author":"CC van den Wijngaard","year":"2017","journal-title":"Eur J Public Health"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.13-0206","article-title":"Initial and long-term costs of patients hospitalized with West Nile virus disease","volume":"90","author":"JE Staples","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"ref39","first-page":"1","article-title":"The potential economic burden of Zika in the continental United States","volume":"11","author":"BY Lee","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00002281-199903000-00004","article-title":"Evaluating costs of rheumatic diseases: a literature review","volume":"11","author":"J Ruof","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002281-200303000-00007","article-title":"Cost-effectiveness, cost-utility, and cost-benefit studies in rheumatology: A review of the literature, 2001\u20132002","volume":"15","author":"MN Tella","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jama.2013.278331","article-title":"CDC Estimates 300 000 US Cases of Lyme Disease Annually","volume":"310","author":"BM Kuehn","year":"2013","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMp1607146","article-title":"Need for a New Lyme Disease Vaccine","volume":"375","author":"SA Plotkin","year":"2016","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.14745\/ccdr.v44i10a03","article-title":"A scoping review of Lyme disease research relevant to public health","volume":"44","author":"JD Greig","year":"2018","journal-title":"Canada Commun Dis Rep"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.14745\/ccdr.v44i10a01","article-title":"The continued rise of Lyme disease in Ontario, Canada: 2017","volume":"44","author":"MP Nelder","year":"2018","journal-title":"Can Commun Dis Rep"},{"key":"ref46","unstructured":"European Centre for Disease Prevention and Control. Lyme Borreliosis in Europe [Internet]. 2014. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/healthtopics\/vectors\/world-health-day-2014\/Documents\/factsheet-lyme-borreliosis.pdf<\/ext-link>"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.vaccine.2009.06.035","article-title":"WHO Guide for standardisation of economic evaluations of immunization programmes","volume":"28","author":"DG Walker","year":"2010","journal-title":"Vaccine"},{"key":"ref48","unstructured":"National Institute for Health and Care Excellence. The guidelines manual | Guidance and guidelines | NICE [Internet]. 2012. https:\/\/www.nice.org.uk\/process\/pmg6\/chapter\/assessing-cost-effectiveness<\/ext-link>"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T15:38:15Z","timestamp":1588952295000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210280"}},"subtitle":[],"editor":[{"given":"Giampiero","family":"Favato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210280","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]}}}